Robust and inducible genome editing via an all-in-one prime editor in human pluripotent stem cells
2024

New Prime Editing Tool for Stem Cells

publication Evidence: high

Author Information

Author(s): Wu Youjun, Zhong Aaron, Sidharta Mega, Kim Tae Wan, Ramirez Bernny, Persily Benjamin, Studer Lorenz, Zhou Ting

Primary Institution: Sloan-Kettering Institute for Cancer Research

Hypothesis

Can a new prime editing platform improve genome editing efficiency in human pluripotent stem cells?

Conclusion

The iPE-Plus platform allows for efficient and controllable multiplex editing in human pluripotent stem cells.

Supporting Evidence

  • The PE-Plus platform demonstrated over 50% efficiency in creating disease-associated mutations.
  • The platform allows for the generation of monoallelic and biallelic mutations.
  • iPE-Plus enables temporal control of gene editing in stem cells.

Takeaway

Scientists created a new tool that helps change genes in stem cells more easily and accurately, which could help in studying diseases.

Methodology

The study involved creating a new prime editing tool called PE-Plus and testing its efficiency in human pluripotent stem cells.

Limitations

The study does not specify limitations, but challenges in editing efficiency compared to other methods are mentioned.

Digital Object Identifier (DOI)

10.1038/s41467-024-55104-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication